Nebulised corticosteroids in the treatment of patients with asthma

Thorax

Volumn 54, Issue 8, 1999, Pages 661-663

  Hill, Jennifer M ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PREDNISOLONE; SALBUTAMOL;

ADOLESCENT; ADRENAL SUPPRESSION; ADULT; ASTHMA; BODY GROWTH; BONE GROWTH; CHILD; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EOSINOPHIL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; MYCOSIS; ORAL DRUG ADMINISTRATION; PEDIATRICS; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0032795314     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.8.661     Document Type: Editorial

References (22)

1. 1 British Thoracic Society, et al. British guidelines on asthma management: 1995 review and position statement. Thorax 1997;52(Suppl 1):S1-21.
2. 2 Pedersen S, Hansen OR. Dose response relationships to nebulised budesonide in children with asthma. Am J Respir Crit Care Med 1997;155:A268.
3. 3 Mellon M, White M, Walton-Bowen K, et al. The efficacy of four dose regimens of budesonide nebulizing suspension (BNS; Pulmicort Respules) compared to placebo (PBO) in infants and young children with persistent asthma. Am J Respir Crit Care Med 1998;157:A404.
4. 4 Otulana BA, Varma N, Bullock A, et al. High dose nebulized steroid in the treatment of steroid-dependent asthma. Respir Med 1992;86:105-8.
5. 5 Higgenbottam TW, Clark RA, Luksza AR, et al. The role of nebulised budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res 1994;5:1-10.
6. 6 Efthimiou J, Westbrock J, Saarelainen S, et al. Oral steroid-sparing effect of nebulised fluticasone propionate at two dose levels with placebo over a three month period in patients with severe asthma. Am J Respir Crit Care Med 1998;157:A404.
7. 7 O'Reilly JF, Weir DC, Banham S, et al. Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics? Respir Med 1998;92:111-7.
8. 8 Leblanc P, Mink S, Keistinen P, et al. A comparison of fluticasone propionate 200 mcg/day with beclomethasone dipropionate 400 mcg/day in adult asthma. Allergy 1994;49:380-5.
9. 9 Bisgaard H, Nikander K, Munch E. Comparative study of budesonide as a nebulized suspension vs. pressurized metered-dose inhaler in adult asthmatics. Respir Med 1998;92:44-9.
10. 10 Toogood JH, Baskerville J, Jennings B, et al. Bioequivalent doses of budesonide and prednisolone in moderate and severe asthma. J Allergy Clin Immunol 1989;84:688-700.
11. 11 Wilson AW, McFarlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulised budesonide in adult asthmatics. Chest 1998;114:1022-7.
12. 12 Baker J, Yunginger J, Walton-Bowen K, et al. A safety and HPA-axis evaluation of four dose regimens of budesonide nebulizing suspension (BNS; Pulmicort respules) compared to placebo (PBO) in infants and young children with persistent asthma. Am J Respir Crit Care Med 1998;157:A405.
13. 13 Reid A, Murphy C, Steen HJ, et al. Linear growth of very young asthmatic children treated with high-dose nebulized budesonide. Acta Paediatr 1996; 85:421-4.
14. 14 Biraghi M, Fano M, Kantar A, et al. Bone turnover in asthmatic children during treatment with nebulized flunisolide: a multicenter Italian study. Eur Respir J 1998;12:86s.
15. 15 Nosetti L, Salvatoni A, Chiappa L, et al. Bone metabolism and steroids nebulising therapy longitudinal study in asthmatic children. Eur Respir J 1998; 2:87s.
16. 16 Scarfone RJ, Loiselle JM, Wiley JF, et al. Nebulized dexamethasone versus oral prednisolone in the emergency treatment of asthmatic children. Ann Emerg Med 1995;26:480-6.
17. 17 Curtis P. Comparison of prednisolone and nebulised budesonide in acute asthma in children: a pilot study. Eur Respir J 1995;8:470s.
18. 18 Bingham A, Manjra AL, Lee BW, et al. A comparison of the effect of nebulised fluticasone propionate 1 mg twice daily with oral prednisolone in children aged 4-16 years with an acute exacerbation of asthma. Am J Respir Crit Care Med 1998;157:A404.
19. 19 Francis P, Geelhoed G, Harris MA, et al. Effect of nebulised fluticasone propionate 1 mg twice daily compared with oral prednisolone in pre-school children aged 48 months or less with an acute exacerbation of asthma. Eur Respir J 1997;10:275s.
20. 20 Winter JH, Dhillon DP, Winter JE, et al. Effect of early substitution of nebulised fluticasone propionate 2 mg bd for oral prednisolone 50 mg od in adults during the early recovery period of an acute exacerbation. Eur Respir J 1997;10:174s.
21. 21 Walsh LJ, Wong CA, Cooper S, et al. Morbidity from asthma in relation to regular treatment: a community based study. Thorax 1999;54:296-300.
22. 22 Thomas PS, Geddes DM, Barnes PJ. Pseudo-steroid resistant asthma. Thorax 1999;54:352-6.